REQUEST A DEMO
Total
USD $0.00
Search more companies

China Regenerative Medicine International Limited (Hong Kong SAR, China)

Main Activities: Medical Equipment and Supplies Manufacturing | Professional, Scientific, and Technical Services
Full name: China Regenerative Medicine International Limited Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

China Regenerative Medicine International Limited is an enterprise based in Hong Kong SAR, China. Its main office is in Hong Kong. It operates in the Medical Equipment and Supplies Manufacturing sector. China Regenerative Medicine International Limited was incorporated on April 20, 2001. The total number of employees is currently 46 (2023). In Q2C2024, the company reported a net sales revenue drop of 40.27%. Over the same period, its total assets decreased by 48.74%. In 2024, China Regenerative Medicine International Limited’s net profit margin increased by 15.4%.

Headquarters
10th Floor, Dah Sing Financial Centre, 108 Gloucester Road, Wanchai, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the China Regenerative Medicine International Limited report to view the information.

Website: http://www.crmi.hk

Basic Information
Total Employees:
Purchase the China Regenerative Medicine International Limited report to view the information.
Outstanding Shares:
Purchase the China Regenerative Medicine International Limited report to view the information.
Registered Capital:
Purchase the China Regenerative Medicine International Limited report to view the information.
Financial Auditors:
Purchase the China Regenerative Medicine International Limited report to view the information.
Incorporation Date:
April 20, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Operating Officer
Ownership Details
Purchase this report to view the information.
29.9%
Purchase this report to view the information.
0.1%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
China Bio-Med Regeneration Technology Limited (United Kingdom)
100%
Crmi Hk Asset Management Limited
100%
Crmi Hk Health Technology Limited
100%
Company Performance
Financial values in the chart are available after China Regenerative Medicine International Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-40.27%
Total operating revenue
-40.2%
Operating profit (EBIT)
52.9%
EBITDA
34.9%
Net Profit (Loss) for the Period
31.86%
Total assets
-48.74%
Total equity
-77.49%
Operating Profit Margin (ROS)
17.8%
Net Profit Margin
15.4%
Return on Equity (ROE)
55.52%
Debt to Equity Ratio
185.73%
Quick Ratio
-0.25%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?